이중특이성 항체 시장

This report provides an overview of the global bispecific antibodies market and analyzes market trends. It includes global revenue ($ million) for the base year data for 2022- 2024 and estimated data for the forecast period from 2025 through 2030.

Report Scope

The report provides an overview of the global market for bispecific antibodies. It includes global revenue ($ million) for the base year of 2024, estimated revenue for 2025, and data for the forecast period 2026 through the end of 2030. The report also analyzes and segments the global bispecific antibodies market by route of administration, mechanisms of action, application, and end user. It also provides insights into key emerging trends and potential growth drivers. The study focuses on the route of administration, including intravenous (IV), subcutaneous (SC), and other. The market is segmented by application into cancer treatment, autoimmune disorders, and other. By mechanism of action, the market focuses on T-cell redirecting bispecific antibodies, dual-antigen tumor-targeting bispecific antibodies, and other. The market is segmented by end users as pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic and research institutions.

The report provides a comprehensive regional analysis covering North America, Europe, Asia-Pacific, South America, the Middle East, and Africa. It evaluates market dynamics, including drivers, challenges, and emerging trends, while highlighting innovations in product and performance enhancements. The study concludes with an analysis of major companies and their offerings.

Report Includes

• Analysis of the global market for bispecific antibodies (bsAbs), a novel approach to anticancer therapy
• Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2025 and projections of CAGRs through 2030
• Estimates of the current market size and revenue prospects for the global market, accompanied by a market share analysis by route of administration, mechanisms of action, application, end user, and region
• Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impact of macroeconomic variables
• Insights derived from Porter's Five Forces model, as well as global supply chain analyses
• Patent review, featuring key granted and published patents
• Analysis of the industry structure, including companies' market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• Profiles of the leading global companies

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Overview
• Future Outlook
• Macroeconomic Factors Analysis
• Demographic Factors
• Global Economic Growth
• Impact of U.S. Tariffs
• Impact of the Ukraine-Russia War on the Bispecific Antibodies Industry
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Threat of Substitutes
• Competitiveness in the Industry

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Global Burden of Cancer
• R&D Investment by Large Pharmaceutical and Biotechnology Companies
• Growing Adoption of Immuno-Oncology Therapies in Standard Treatment Pathways
• Market Restraints
• High Treatment Cost and Pricing Pressure
• Shortage of Oncology Professionals
• Stringent Government Regulations
• Market Opportunities
• Development of Bispecific Antibodies for Solid Tumors
• Expansion in Emerging Markets

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Europe
• Asia-Pacific

Chapter 5 Emerging Technologies

• Overview
• Newest Technologies/Trends
• Next-Generation Bispecific Antibody Formats with Improved Stability and Half-Life
• Subcutaneous and Outpatient Administration Optimized Bispecific Antibodies
• AI-Assisted Antibody Design and Target Selection
• Combination Regimens with Immune Checkpoint Inhibitors or Targeted Therapies
• Conditional Activation and Tumor-Restricted Bispecific Designs

Chapter 6 Market Segment Analysis

• Segmentation Breakdown
• Global Bispecific Antibodies Market, by Route of Administration
• Key Takeaways
• Intravenous (IV)
• Subcutaneous (SC)
• Others
• Global Bispecific Antibodies Market, by Application
• Key Takeaways
• Cancer Treatment
• Autoimmune Disorders
• Others
• Global Bispecific Antibodies Market, by Mechanisms of Action
• Key Takeaways
• T-cell Redirecting Bispecific Antibodies
• Dual-Antigen Tumor-targeting Bispecific Antibodies
• Others
• Global Bispecific Antibodies Market, by End User
• Key Takeaways
• Pharmaceutical and Biotechnology Companies
• CROs
• Academic and Research Institutions
• Geographic Breakdown
• Global Bispecific Antibodies Market, by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America

Chapter 7 Clinical Trial and Patent Analyses

• Clinical Trial Analysis
• Key Takeaway
• Patent Analysis
• Key Takeaways
• Patents, by Jurisdiction
• Patents, by Applicants

Chapter 8 Competitive Intelligence

• Key Takeaways
• Strategic Analysis

Chapter 9 Appendix

• Research Methodology
• Sources
• Acronyms
• Company Profiles
• ABBVIE INC.
• AMGEN INC.
• ASTRAZENECA
• BRISTOL-MYERS SQUIBB CO.
• F. HOFFMANN-LA ROCHE LTD.
• JAZZ PHARMACEUTICALS INC.
• JOHNSON & JOHNSON
• LILLY USA LLC.
• PFIZER INC.
• REGENERON PHARMACEUTICALS INC.
• Emerging Start-ups/ Market Disruptors